Biodel and Albireo Limited
26 September 2016 Articles
Biodel Inc. (NASDAQ: BIOD) today announced that its 2016 annual meeting of stockholders has been set for October 24, 2016. At that meeting, stockholders will vote on, among other things, matters necessary to complete Biodel’s planned transaction with Albireo Limited pursuant to a previously announced share exchange agreement, including the issuance of shares of Biodel’s common stock in the transaction and a proposed reverse stock split of Biodel’s common stock at a ratio of 1-for-30 shares.
Morrow Sodali is acting as proxy solicitor for Biodel Inc.
Related News
Sodali & Co Debt Team supports Ukraine to achieve budget liquidity and financial stability
12 September 2024
Banco Sabadell to file a complaint with the Spanish National Securities Market Commission (CNMV) alleging that BBVA violated takeover regulations
10 May 2024
Morrow Sodali Names Barri Rafferty as CEO of the Americas
05 September 2023
Morrow Sodali proud to play a key role in Ukraine's successful debt deferral
04 October 2022
Media enquiries
To contact our global experts for comments please get in touch below.
Contact us chevron_right